Credit: John Moore/Getty Images
Quality Journalism for Critical Times
WASHINGTON — Medicare can now negotiate lower prices for 10 common high-price drugs, cutting out-of-pocket costs for an estimated 9 million seniors and saving taxpayers billions, the Biden administration said Tuesday.
Medicare will begin this year to negotiate with the manufacturers of popular medications used to treat blood clots, diabetes, heart disease, rheumatoid arthritis, chronic kidney disease, psoriasis, blood cancers, Crohn’s disease and ulcerative colitis.
Enrollees will begin to see lower prices in 2026.
The prescription drug negotiations are a result of last year’s Inflation Reduction Act, a massive spending package that contained measures
Disclaimer: This article may require a subscription.
English 
Español de México